F. Bray, A. Jemal, N. Grey, J. Ferlay, and D. Forman, Global cancer transitions according to the Human Development Index (2008???2030): a population-based study, The Lancet Oncology, vol.13, issue.8, pp.790-801, 2012.
DOI : 10.1016/S1470-2045(12)70211-5

S. Hantz, A. S. Denis, and F. , Vaccins anti-papillomavirus et pr??vention du cancer du col de l???ut??rus, La Presse M??dicale, vol.34, issue.10, pp.745-53, 2005.
DOI : 10.1016/S0755-4982(05)84030-8

J. Eluf-neto and C. Nascimento, Cervical cancer in Latin America, Seminars in Oncology, vol.28, issue.2, pp.188-97, 2001.
DOI : 10.1053/sonc.2001.21966

T. Roue, M. Nacher, A. Fior, J. Plenet, S. Belliardo et al., Cervical Cancer Incidence in French Guiana, International Journal of Gynecological Cancer, vol.22, issue.5, pp.850-853, 2012.
DOI : 10.1097/IGC.0b013e318251722c

A. Van-melle, M. Parriault, C. Basurko, A. Jolivet, C. Flamand et al., Knowledge, attitudes, behaviors, and practices differences regarding HIV in populations living along the Maroni river: particularities of operational interest for Amerindian and Maroon populations, AIDS Care, vol.73, issue.9, pp.1112-1119, 2015.
DOI : 10.1371/journal.pone.0053065.t001
URL : https://hal.archives-ouvertes.fr/hal-01260915

M. Nacher, V. Vantilcke, M. Parriault, A. Van-melle, M. Hanf et al., What is driving the HIV epidemic in French Guiana?, International Journal of STD & AIDS, vol.21, issue.5, pp.359-61, 2010.
DOI : 10.1258/ijsa.2010.009570

M. Douine, T. Roue, A. Fior, A. Adenis, N. Thomas et al., Survival of patients with invasive cervical cancer in French Guiana, 2003-2008, International Journal of Gynecology & Obstetrics, vol.125, issue.(2), pp.166-173, 2003.
DOI : 10.1016/j.ijgo.2013.10.031
URL : https://hal.archives-ouvertes.fr/inserm-01065103

M. Lam-fouk and S. , Histoire générale de la Guyane française. 2 ed. Matoury: Ibis Rouge Éditions, 2002.

D. Solomon, D. Davey, R. Kurman, A. Moriarty, O. Connor et al., Forum Group Members, 2001.

. Workshop, The 2001 Bethesda System : terminology for reporting results of cervical cytology, JAMA, vol.287, issue.16, pp.2114-2123, 2002.

A. Fonseca, D. Taeko, T. Chaves, L. Amorim, R. Murari et al., HPV Infection and Cervical Screening in Socially Isolated Indigenous Women Inhabitants of the Amazonian Rainforest, PLOS ONE, vol.6, issue.3, 2015.
DOI : 10.1371/journal.pone.0133635.s001

S. Franceschi, R. Herrero, G. Clifford, P. Snijders, A. Arslan et al., Variations in the age-specific curves of human papillomavirus prevalence in women worldwide, International Journal of Cancer, vol.91, issue.11, pp.2677-84, 2006.
DOI : 10.1002/ijc.22241

I. Heard, L. Tondeur, L. Arowas, M. Falguières, and M. Demazoin, Distribution des papillomavirus humains (HPV) dans des frottis effectués dans le cadre du dépistage organisé du cancer du col de l'utérus en France, Bull Epidémiol Hebd, pp.241-249, 2014.

G. Ayhan, L. Martin, M. Levy-loeb, S. Thomas, G. Euzet et al., Prevalence and risk factors of early onset of sexual intercourse in a random sample of a multiethnic adolescent population in French Guiana, AIDS Care, vol.27, issue.8, pp.1025-1055, 2015.
DOI : 10.1016/S0368-2315(06)76372-4

D. Forman, C. De-martel, C. Lacey, I. Soerjomataram, J. Lortet-tieulent et al., Global Burden of Human Papillomavirus and Related Diseases, Vaccine, vol.30, issue.5, pp.12-23, 2012.
DOI : 10.1016/j.vaccine.2012.07.055

E. Lazcano-ponce, R. Herrero, N. Muñoz, A. Cruz, K. Shah et al., Epidemiology of HPV infection among Mexican women with normal cervical cytology, International Journal of Cancer, vol.91, issue.3, pp.412-432, 2001.
DOI : 10.1002/1097-0215(20010201)91:3<412::AID-IJC1071>3.0.CO;2-M

M. Molano, A. Van-den-brule, M. Plummer, E. Weiderpass, H. Posso et al., Determinants of Clearance of Human Papillomavirus Infections in Colombian Women with Normal Cytology: A Population-based, 5-Year Follow-up Study, American Journal of Epidemiology, vol.158, issue.5, pp.486-94, 2003.
DOI : 10.1093/aje/kwg171

P. Toliman, S. Badman, J. Gabuzzi, S. Silim, L. Forereme et al., Field Evaluation of Xpert HPV Point-of-Care Test for Detection of Human Papillomavirus Infection by Use of Self-Collected Vaginal and Clinician-Collected Cervical Specimens, Journal of Clinical Microbiology, vol.54, issue.7, pp.1734-1741, 2016.
DOI : 10.1128/JCM.00529-16

E. Lynge, L. Clausen, R. Guignard, and P. Poll, What happens when organization of cervical cancer screening is delayed or stopped?, Journal of Medical Screening, vol.13, issue.1, pp.41-47, 2006.
DOI : 10.1258/096914106776179773

R. Sankaranarayanan, B. Nene, S. Shastri, K. Jayant, R. Muwonge et al., HPV Screening for Cervical Cancer in Rural India, New England Journal of Medicine, vol.360, issue.14, pp.1385-94, 2009.
DOI : 10.1056/NEJMoa0808516

P. Londesborough, L. Ho, G. Terry, J. Cuzick, C. Wheeler et al., Human papillomavirus genotype as a predictor of persistence and development of high-grade lesions in women with minor cervical abnormalities, International Journal of Cancer, vol.69, issue.5, pp.364-372, 1996.
DOI : 10.1002/(SICI)1097-0215(19961021)69:5<364::AID-IJC2>3.0.CO;2-3

C. Bergeron, I. Cartier, L. Guldner, M. Lassalle, A. Savignoni et al., Lésions précancéreuses et cancers du col de l'utérus diagnostiqués par le frottis cervical, Île-de-France, enquête Crisap, Bull Epidémiol Hebd, issue.2, pp.5-6, 2002.

D. Riethmuller, A. Jacquard, L. St-guily, J. Aubin, F. Carcopino et al., Potential impact of a nonavalent HPV vaccine on the occurrence of HPV-related diseases in France, BMC Public Health, vol.134, issue.9, p.453, 2015.
DOI : 10.1002/ijc.28541
URL : https://hal.archives-ouvertes.fr/hal-01153727

T. Roué, M. Nacher, J. Droz, B. Carme, P. Couppié et al., Epidemiology of cancer in the tropical areas, Tropical hemato-oncology. Cham (ZG), pp.17-23, 2015.

G. Broberg, D. Gyrd-hansen, M. Jonasson, J. Ryd, M. Holtenman et al., Increasing participation in cervical cancer screening : offering a HPV self-test to longterm non-attendees as part of RACOMIP, a Swedish randomized controlled trial Primary cervical cancer screening with human papillomavirus : end of study results from the ATHENA study using HPV as the first-line screening test, Int J Cancer. Gynecol Oncol, vol.134136, issue.92, pp.189-97, 2014.